Intraoperative High-Dose Dexamethasone for Cardiac Surgery: A Randomized Controlled Trial
In our trial of adults undergoing cardiac surgery, the use of intraoperative dexamethasone did not reduce the 30-day incidence of major adverse events compared with placebo.